Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the effect of statin in patients with heart failure
IRCT2015010320538N1Phase 3Completed
- Sponsor
- Louisville Metabolic and Atherosclerosis Research Center
- Start
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of ulinastatin in heart failure with preserved ejection fraction (HFpEF), sponsored by Louisville Metabolic and Atherosclerosis Research Center. Started Nov 2014; status: completed.
02
Drugs
ulinastatin
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on IRCT2015010320538N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015010320538N1.